REVOFIL AQUASHINE PTX

Key Uses of Revofil Aquashine PTX 1x2ml

Revofil Aquashine PTX is suitable for a variety of aesthetic treatments, offering natural-looking rejuvenation in key areas:

• Face: Softens fine lines and restores skin volume.
• Neck and décolletage: Improves skin firmness and elasticity.
• Hands: Rejuvenates and smooths ageing skin.
• Forehead and glabella: Reduces dynamic wrinkles without restricting movement.
• Periorbital and perioral areas: Treats crow’s feet, nasolabial folds, and smoker’s lines.

Who Manufactures Revofil Aquashine?

Revofil Aquashine PTX is developed by Caregen, a South Korean biotechnology company specialising in peptide-based regenerative medicine. 

Revofil wide range of products includes:

• Revofil Fine: A soft filler for superficial wrinkles.
• Revofil Plus: For deeper wrinkles and volume enhancement.
• Revofil Ultra: Designed for deep tissue support and contouring.
• Revofil Aquashine BR Soft Filler 1x2ml: Targets pigmentation and skin brightening. Also available as Revofil Aquashine BR Soft Filler 2x2ml.
• Revofil Aquashine PTX 1x2ml: Provides the same effects only in a single-use syringe pack.
• Revofil Aquashine Soft Filler: A combination filler for overall skin improvement.

Expected Benefits and Results of the Treatments

Revofil Aquashine PTX provides multiple skin-enhancing benefits, helping patients achieve a youthful and revitalised appearance:

• Deep hydration: Enhances skin moisture retention.
• Wrinkle reduction: Minimises fine lines and smooths skin texture.
• Volume restoration: Restores youthful fullness to targeted areas.
• Skin tightening: Firms sagging skin and improves elasticity.
• Long-lasting effects: Results last for several months.
• Non-invasive treatment: Minimal downtime with natural-looking outcomes.

Revofil Aquashine PTX Key Ingredients and Device Features

Revofil Aquashine PTX contains a range of advanced ingredients and device properties designed to optimise results:

Key ingredients:

• Decapeptide-29: Promotes skin smoothing and firming.
• Oligopeptide-62: Helps tighten and lift sagging skin.
• Oligopeptide-34: Reduces pigmentation and brightens skin.
• Oligopeptide-51: Supports skin regeneration.
• Acetyl Decapeptide-3: Enhances skin elasticity and texture.
• Oligopeptide-24: Stimulates collagen production for anti-ageing benefits.
• Oligopeptide-72: Provides antioxidant protection.
• Sodium Hyaluronate (15 mg/ml): Deeply hydrates and plumps the skin.

Device properties:

• Optimised viscosity: Ensures smooth, even distribution.
• Biocompatible formulation: Minimises risk of irritation.
• Soft gel texture: Enables easy application and natural-looking results.

Included Items or Accessories

The Revofil Aquashine PTX package includes all the necessary components for safe and efficient administration:

• One prefilled syringes, 2ml each.
• One 32G1/2” needles.
• Product information leaflet.
• One traceability stickers.

Administration Method for Revofil Aquashine PTX

To ensure optimal results, medical professionals should follow these steps:

Pre-procedure:

• Cleanse and disinfect the injection area.
• Apply numbing cream if necessary.
• Prepare the syringe and attach the needle.

During procedure:

• Use mesotherapy or microinjection techniques.
• Inject in multiple points for even distribution.
• Adjust depth based on treatment area.

After procedure:

• Gently massage the area for even absorption.
• Apply a post-treatment soothing cream.
• Instruct patients on proper aftercare.

Guidelines for Proper Aftercare

After the procedure, patients should follow these aftercare instructions:

• Avoid touching the treated area for 24 hours.
• Stay out of direct sunlight for at least a week.
• Refrain from vigorous exercise for 24 hours.
• Avoid makeup and skincare products for 12 hours post-treatment.

Duration of Revofil Aquashine Soft Filler Effects

Results typically last up to a year, with touch-up treatments recommended every 6-9 months to maintain optimal results.

Potential Risks and Side Effects

As with any injectable treatment, Revofil Aquashine PTX may cause some side effects, though most are mild and temporary. Medical professionals should inform patients about possible reactions to ensure safe and effective treatment.

Common side effects:

• Redness and swelling: Mild inflammation at the injection site, typically resolving within a few hours to a couple of days.
• Bruising: Minor bruising, especially in patients with sensitive skin or vascular fragility.
• Tenderness or discomfort: Some sensitivity in the treated area, usually disappearing within 24-48 hours.
• Itching or irritation: A mild tingling or itching sensation as the skin adjusts to the product.
• Lumps or uneven texture: Temporary irregularities that typically smooth out on their own or with gentle massage.
• Temporary numbness or tingling: Some patients report a slight numbing effect that fades within a few days.

Rare side effects:

• Allergic reactions: In rare cases, hypersensitivity may cause prolonged swelling, hives, or excessive redness.
• Infection at the injection site: Improper sterilisation can lead to bacterial infections, requiring medical treatment.
• Vascular occlusion: If injected incorrectly, the filler may block blood flow, potentially leading to skin discolouration or necrosis.
• Granulomas: Firm nodules under the skin may form as a result of an immune response to the filler.
• Persistent pain or swelling: Uncommon but may indicate an adverse reaction requiring professional evaluation.

Revofil Aquashine PTX Treatment Contraindications

Revofil Aquashine PTX is a highly effective combination of dermal filler and mesotherapy injection, but it is not suitable for all patients. Medical professionals should carefully evaluate each individual’s health condition before proceeding with treatment.

• Individuals with autoimmune diseases: Conditions such as lupus or rheumatoid arthritis may trigger an adverse immune response.
• Patients with compromised immune systems: Those undergoing chemotherapy, long-term corticosteroid treatment, or suffering from chronic illnesses may have a higher risk of complications.
• People with vascular disorders or a history of vascular occlusion: These patients have an increased risk of ischemia or necrosis if the filler is injected incorrectly.
• Individuals taking anticoagulants or blood-thinning medication: Medications like warfarin and aspirin increase the risk of excessive bruising and prolonged bleeding.
• Patients with a history of severe allergic reactions (anaphylaxis): Those prone to serious allergic responses should avoid this treatment.
• Individuals with hypersensitivity to hyaluronic acid or peptides: Allergic reactions to the filler’s ingredients may cause severe swelling or irritation.
• Those with a history of keloid or hypertrophic scarring: Patients prone to abnormal scar formation may develop nodules or raised scars at the injection site.
• Pregnant or breastfeeding women: The effects of Revofil Aquashine PTX on foetal development and lactation are unknown, making treatment inadvisable.
• Individuals under 18 years of age: This treatment is intended for adult patients only and should not be administered to minors.
• Patients with diabetes or poor wound healing: These individuals are at a higher risk of infection and delayed recovery.
• Individuals with active skin infections: Conditions such as herpes, acne, or eczema at the injection site can increase the likelihood of complications.
• Patients with recent facial surgery or invasive aesthetic procedures: Injecting into areas that have not fully healed may lead to complications and affect the final results.
• Those with neurological disorders: Conditions such as myasthenia gravis or multiple sclerosis require specialist consultation before treatment.